(KRYS) - Analyzing Krystal Biotech's Short Interest
Portfolio Pulse from Benzinga Insights
Krystal Biotech's (NYSE:KRYS) short interest has risen by 4.43%, with 16.96% of its float sold short. This is higher than its peers' average of 14.74%. It would take traders 13.21 days to cover their short positions.
July 30, 2024 | 6:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Krystal Biotech's short interest has increased by 4.43%, with 16.96% of its float sold short. This is higher than the peer group average of 14.74%. It would take traders 13.21 days to cover their short positions.
The increase in short interest suggests that investors are becoming more bearish on Krystal Biotech. The high percentage of float sold short and the time required to cover these positions could put downward pressure on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100